Canine atopic dermatitis causes chronic pruritus that significantly reduces quality of life and requires modern multimodal management for adequate welfare.
Canine atopic dermatitis is a quality of life catastrophe for severely affected dogs. Chronic itch is inherently distressing — the constant urge to scratch disrupts rest, damages social relationships, and creates a cycle of self-trauma, secondary infection, and worsening skin barrier function. Dogs with poorly controlled atopy scratch, lick, and chew constantly, show disrupted sleep patterns, reduced play engagement, and signs of chronic discomfort. The emergence of targeted biologics — particularly lokivetmab and oclacitinib — has transformed management options compared to systemic corticosteroid approaches that controlled itch at the cost of significant side effects. Modern multimodal management combining targeted antipruritic therapy with regular medicated bathing, barrier-restoring topicals, and allergen avoidance can achieve excellent welfare outcomes for most atopic dogs.